Medical Device News Magazine

Kevin Campbell Joins Vita Inclinata As Executive Vice President of Finance

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Vita Inclinata (Vita), developer and producer of precision aerospace and industrial stabilization devices, today announced the appointment of Kevin Campbell as Executive Vice President of Finance.

Kevin Campbell is an experienced financial executive with a strong mix of technical, operational, strategic, and commercial finance skills and a history of building, leading, and motivating teams in high-growth, investment-oriented businesses.

Kevin Campbell’s goal at Vita is to create shareholder value by ensuring the company makes the best investment decisions to take advantage of its significant organic and acquisition-related growth opportunities. In addition, he will be focused on scaling the finance and accounting functions to support this rapid growth.

Kevin Campbell said, “I am impressed by Vita’s life-saving technology and its impact within the aerospace and industrial markets and am excited to be part of an organization dedicated to saving lives. My background in driving operational improvements, overseeing capital market and corporate development activities, and building teams will better position Vita for its next growth phase.”

Most recently, Campbell was Senior Vice President of Treasury and Corporate Development at Air Methods, which provides emergency medical services to over 100,000 patients annually in 48 states. In this position, he was responsible for capital and investment management, corporate development, capital market activities, treasury, and investor relations. He also previously served as the Senior Vice President of Corporate Finance at Air Methods where he managed the annual budget, quarterly forecast, and management reporting processes, among other things. Before joining Air Methods, Campbell served as Managing Director at Avondale Partners, a boutique investment bank where he wrote research on publicly-traded companies. He began his career at Greenwich Alternative Investments, where he was responsible for qualitative research on hedge funds, managing three funds that invested in other hedge funds, and the firm’s relationships with its largest institutional investors.

“Kevin Campbell’s leadership experience and ability to position corporate financial systems for notable growth is an outstanding addition to our executive team,” said Caleb Carr, CEO of Vita. “His demonstrated experience financially guiding an aviation medical company to national success parallels Vita’s growth goals. We are eager to benefit from the dividends his experience will bring to our organization.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”